MCI: Clinical Trials

55 trials for MCI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 13 recruiting, 10 unknown, 7 not yet recruiting. 30 Not applicable, 5 Phase 1, 3 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable30Completed 9, Unknown 7, Not yet recruiting 6, Recruiting 5, Active not recruiting 2, Enrolling by invitation 1
Phase 15Recruiting 3, Completed 2
Phase 23Recruiting 2, Completed 1
Early Phase 11Completed 1

Follow MCI: new trials by email Literature Review of MCI trials Research Report on MCI

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Developing and Testing an AI-Based Cognitive Intervention Program
Lifestyle Intervention - Intact Cognitive Function, MCI
Not applicableNot yet recruitingNational Research Center for Rehabilitation Technical Aids1002026-11-012026-08-18
Personalized Closed-Loop Brain Stimulation for Patients With Mild Cognitive Impairment
Active tES, Cognitive Interventions - MCI
Not applicableNot yet recruitingJohns Hopkins University102026-11-012026-10-07
Cognitive-Motor Training for AD/ADRD Prevention
Novel CogXergaming Training, Exercise and Education Training Program - MCI, Aging
Not applicableNot yet recruitingUniversity of Illinois at Chicago462026-10-012026-08-18
Tailored Brain Health Insights Through Nurturing Knowledge-based Change - Stakeholder-driven, Human-centered, AI-powered Refinement for Prevention
BLAZE (Brain health Lifestyle Action with personaliZed Engagement) - MCI, Dementia
Not applicableNot yet recruitingAlexandra Hospital3502026-09-012026-05-29
The Effect of Lavender Aromatherapy on Cognitive Function in Older Adults With Mild Cognitive Impairment
aromatherapy - MCI
Not applicableNot yet recruitingChina Medical University, China702026-09-012026-07-07
Ketogenic Diet to Reduce Osteoarthritis Pain in MCI
Well-formulated ketogenic diet - Osteoarthritis (OA) of the Hip, Osteoarthritis (OA) of the Knee
Not applicableNot yet recruitingUniversity of Kansas Medical Center102026-06-012026-05-04
Telehealth-Adapted Compensatory Training and Intervention for Cognition
Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT-MCI), Brief Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (bME-CCT-MCI) - MCI, Mild Cognitive Impairment
Not applicableRecruitingUniversity of Florida1002026-05-292026-06-03
A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy
[18F]Flortaucipir Injection - AD - Alzheimer's Disease, MCI
Phase 1RecruitingEli Radiopharma182026-04-232026-05-14
Prevalence of Mild Cognitive Impairment and Dementia in Patients Admitted to Non-neurological Rehabilitation Wards
Cognitive and clinical screening, Extended neuropsychological assessment, Blood biomarker sampling and APOE genotyping - MCI, Mild Cognitive Impairment (MCI)
Not applicableRecruitingFondazione Don Carlo Gnocchi ETS3842026-01-202026-08-10
Validation of the Montreal Cognitive Assessment (MoCA) Version 8.x and MoCA-MIS in Greece.
MCI, Dementia
Not yet recruitingAristotle University Of Thessaloniki2502026-01-012025-12-22
FACE Phase II (a Stage II Trial)
Cognitive Remediation, Cognitive Remediation II - MCI, Subjective Cognitive Decline (SCD)
Phase 1 / Phase 2RecruitingStanford University802025-10-312026-04-24
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
[ 18F]3F4AP, [18F]MK6240, [11C]PIB - Demyelinating Disorders, MCI
Phase 1RecruitingYale University1052025-05-052026-09-09
Validation Study of a New Digital Diagnostic and Treatment Test Based on Interactive Video Games for Alzheimer's Disease
Bgaze Therapy, Bgaze Attention Task - Alzheimer Disease, MCI
Not applicableEnrolling by invitationBraingaze602025-05-012025-05-09
Acute Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity
Oral ketone monoester (KME) - MCI, SCD
Not applicableCompletedUniversity Department of Geriatric Medicine FELIX PLATTER152025-04-122026-05-18
Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases
Alzheimer Disease, FTD
RecruitingOspedale Policlinico San Martino12002025-02-282025-11-25
The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients
SGLT2 Is+METFORMIN, DPP4 Is+metformin, Control group - MCI
Active not recruitingBeni-Suef University3002025-01-012026-07-24
Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease
dimethyl fumarate - MCI, MCI-AD, Early Stage Alzheimer's Disease
Phase 2RecruitingMedical University of Lodz302024-10-282025-02-27
ViewMind Atlas Cognition
ViewMind Atlas™ - MCI, Cognitive Ability, General
Not applicableUnknownViewMind2702024-10-162024-12-24
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
MediTrain, wrist worn multi-sensor watches, Sleep monitor - MCI, Aging
Not applicableActive not recruitingUniversity of California, San Francisco902024-09-102026-08-24
Accelerating Cognitive Gains From Digital Inverventions With Noninvasive Brain Stimulation
MediTrain, Worder, noninvasive neurostimulation device - Aging, MCI
Not applicableActive not recruitingUniversity of California, San Francisco902024-08-312026-08-24

Showing 20 of 55. Sign in to see all of them.

Narrower conditions

Cognitive Dysfunction (22)  ·  Alzheimer Disease (18)  ·  Dementia (12)  ·  Motor Activity (3)  ·  Neurocognitive Disorders (3)  ·  Attention Deficit Disorder with Hyperactivity (2)  ·  Behavior (2)  ·  Disease (2)  ·  Fibromyalgia (2)  ·  Multiple Sclerosis (2)  ·  Nerve Degeneration (2)  ·  Parkinson Disease (2)  ·  Alzheimer Disease 10 (1)  ·  Alzheimer Disease 11 (1)  ·  Alzheimer Disease 12 (1)

Broader conditions

Mental Disorders (35)  ·  Neurocognitive Disorders (32)  ·  Nervous System Diseases (30)  ·  Brain Diseases (29)  ·  Central Nervous System Diseases (29)  ·  Cognition Disorders (21)  ·  Neurodegenerative Diseases (19)  ·  Tauopathies (18)  ·  Dementia (16)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Pathologic Processes (6)  ·  Behavior (4)  ·  Neurologic Manifestations (4)  ·  Signs and Symptoms (4)  ·  Immune System Diseases (3)

Interventions

Exercise (2)  ·  Physical Examination (2)  ·  2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1)  ·  7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1)  ·  Aromatherapy (1)  ·  Cognitive Remediation (1)  ·  Control Groups (1)  ·  Dimethyl Fumarate (1)  ·  Indigo Carmine (1)  ·  Methylene Blue (1)  ·  Phenazopyridine (1)  ·  Positron-Emission Tomography (1)  ·  Speech Therapy (1)  ·  Transcranial Magnetic Stimulation (1)

Sponsors

University of California, San Francisco (3)  ·  Braingaze (2)  ·  Chang Gung Memorial Hospital (2)  ·  Johns Hopkins University (2)  ·  QuantalX Neuroscience (2)  ·  University of Illinois at Chicago (2)  ·  iPACES LLC (2)  ·  Accexible (1)  ·  Alexandra Hospital (1)  ·  Altoida (1)  ·  Antalya Training and Research Hospital (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Beni-Suef University (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  China Medical University, China (1)

Countries

United States (21)  ·  China (6)  ·  Italy (4)  ·  Canada (2)  ·  Israel (2)  ·  Spain (2)  ·  Taiwan (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Colombia (1)  ·  Egypt (1)  ·  France (1)  ·  Greece (1)  ·  Japan (1)  ·  Poland (1)

Top investigators

Cay Anderson-Hanley, PhD (3)  ·  David Ziegler, PhD (2)  ·  Kyrana Tsapkini, PhD (2)  ·  Adam Gazzaley, MD/PhD (1)  ·  Andy Liu, MD (1)  ·  Bob Gillen, PhD (1)  ·  Cameron K Perrin, M.S. (1)  ·  Christine Walsh, PhD (1)  ·  Corinne Fischer, MD (1)  ·  Cristina Polito (1)  ·  David A Ziegler, PhD (1)  ·  David Wolk, MD (1)  ·  Donatienne Van Weehaeghe, MD PhD (1)

Results publications

PMID 30200183, PMID 30233154, PMID 22261206, PMID 27337738, PMID 29780318, PMID 27369684, PMID 29424560, PMID 30174426, PMID 30258975, PMID 30607981, PMID 31063176, PMID 33031971, PMID 3338459, PMID 33858238, PMID 34612169, PMID 34875098, PMID 35002683, PMID 36448676, PMID 36564192, PMID 36755377, PMID 37287321, PMID 38144923, PMID 38414877, PMID 38942556, PMID 39096926, PMID 39168498, PMID 39713939, PMID 39713957, PMID 40001837, PMID 40129129, PMID 40917768, PMID 41440544, PMID 41518400, PMID 42831056

NIH funding

P41EB022544 (1), R01AG055005 (1), R01AG076153 (1), R01AG076668 (1), R01AG085561 (1), R01DC014475 (1), R01EB033582 (1), R41AG053120 (1), R61AG080528 (1), R61AG083503 (1)